Date	Period	Revenue/Estimate	Earnings Call
Aug 29, 2025	2026/Q2	-- / 6.500B	--
May 30, 2025	2026/Q1	-- / 6.000B	--
Mar 17, 2025	2025/Q4	5.801B / 5.545B	--
Nov 29, 2024	2025/Q3	5.131B / 4.825B	--
Aug 30, 2024	2025/Q2	4.700B / 4.113B	--

DatePeriodRevenue/EstimateEarnings Call

Aug 29, 20252026/Q2-- / 6.500B--

May 30, 20252026/Q1-- / 6.000B--

Mar 17, 20252025/Q45.801B / 5.545B--

Nov 29, 20242025/Q35.131B / 4.825B--

Aug 30, 20242025/Q24.700B / 4.113B--

Unlock Free Earnings Estimates

Open Account

Tri Chemical Laboratories: Summary of Financial Results for the Fiscal Year Ending January 2025 [Japanese GAAP] (Consolidated)

Mar 14 02:00 ET

Tri Chemical Laboratories: Notice regarding dividends from surplus

Mar 14 02:00 ET

Tri Chemical Laboratories: Notice regarding revisions to full-year earnings forecasts

Feb 14 01:30 ET

Tri Chemical Laboratories: Summary of Financial Results for the 3rd Quarter Ending January 2025 [Japanese GAAP] (Consolidated)

Nov 29, 2024 01:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Mar 13, 2025

Strong Buy

No Data